Most Popular Angioplasty Web Site
supported by Volcano Corporation
Meeting to Highlight Use of New Imaging Technologies for Guiding Stent and Angioplasty Procedures
Intravascular Imaging (OCT, IVUS and FFR) Course To Be Held in Bergamo, Italy, May 28-29
Clockwise: OCT, IVUS, FFR

May 25, 2009 -- This week marks one of the first courses to focus exclusively on the range of innovative intravascular imaging and measurement technologies that have been gaining in use over the past couple of years. "OCT, IVUS, FFR: When, Where, How" will be held on May 28 and 29 in Bergamo, Italy.

The course will utilize the newest innovations in Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Virtual Histology (VH) and Fractional Flow Reserve (FFR) and how they can be used to optimize percutaneous procedures, such as angioplasty and stenting.

The Course Director is Dr. Giulio Guagliumi of Ospedali Riuniti di Bergamo who was the principal investigator for the ODESSA Trial, the first clinical study of stent strut coverage as seen and measured via OCT. Dr. Guagliumi has been one of the pioneering cardiologists in OCT technology and he told Angioplasty.Org that the time had come for a course solely on intravascular imaging modalities. He explained that this interactive course will attempt to define if , when, how and where to use IVUS, VH, OCT and FFR in daily interventional practice, with particular emphasis on what the evolution in current technology will allow cardiologists to do in the near future.

Strategies in complex coronary lesions, atherosclerotic plaque assessment, detection and measurement of stent strut apposition and coverage, thrombus identification and tissue type characterization will all be addressed. The course will include live interactive cases, flash debates followed by voting and carefully selected lectures from internationally recognized experts, as well as multimedia links with the U.S.

    Giulio Guagliumi, MD
Giulio Guagliumi, MD

With the use of FFR as a decision-making tool, as demonstration by the FAME study, the use of stents was reduced by a third, with an increase in positive outcomes for patients. The ability of IVUS to improve stent choice and placement, as well as confirmation of complete stent expansion, has been shown in a number of trials. Now OCT is being utilized to see and measure a number of intravascular characteristics, including whether or not the struts of a stent have been covered, or healed.

The interest in this field has been robust -- Dr. Guagliumi told Angioplasty.Org that his course was already over-subscribed more than a month ago. For more information on OCT, look for Angioplasty.Org's upcoming interview with Dr. Guagliumi.

Reported by Burt Cohen, May 25, 2009